Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial

Glaucoma leads to irreversible blindness. Numerous anti-glaucoma eye drops have been developed. Unfortunately, many patients with glaucoma still suffer from progressive visual disorders. Recently, ripasudil hydrochloride hydrate, a selective Rho-associated protein kinase inhibitor, was launched for...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Sci Rep
Hauptverfasser: Sakamoto, Emi, Ishida, Waka, Sumi, Tamaki, Kishimoto, Tatsuma, Tada, Kentaro, Fukuda, Ken, Yoneda, Tsuyoshi, Kuroiwa, Hajime, Terao, Etsuko, Fujisawa, Yasuko, Nakakura, Shunsuke, Jian, Koji, Okumichi, Hideaki, Kiuchi, Yoshiaki, Fukushima, Atsuki
Format: Artigo
Sprache:Inglês
Veröffentlicht: Nature Publishing Group UK 2019
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6403378/
https://ncbi.nlm.nih.gov/pubmed/30842572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-40255-9
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge